HM
HealthCor Management Portfolio holdings
AUM
$109M
This Quarter Return
+9.44%
1 Year Return
+11.46%
3 Year Return
+50.01%
5 Year Return
+144.68%
10 Year Return
–
AUM
$2.67B
AUM Growth
+$2.67B
(+22%)
Cap. Flow
+$275M
Cap. Flow
% of AUM
10.31%
Top 10 Holdings %
Top 10 Hldgs %
62.01%
Holding
53
New
15
Increased
10
Reduced
9
Closed
16
Top Buys
| 1 |
Danaher
DHR
|
$108M |
| 2 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$108M |
| 3 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
$88.8M |
| 4 |
Cardinal Health
CAH
|
$84.5M |
| 5 |
Hologic
HOLX
|
$76.6M |
Top Sells
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$115M |
| 2 |
AET
Aetna Inc
AET
|
$102M |
| 3 |
Merck
MRK
|
$93.7M |
| 4 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
$77.9M |
| 5 |
Align Technology
ALGN
|
$60.2M |
Sector Composition
| 1 | Healthcare | 93.1% |
| 2 | Financials | 5.12% |
| 3 | Materials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Eli Lilly
LLY
$661B
| $26.9M | 0.97% |
+327,064
| New | +$26.9M |
|
27
LivaNova
LIVN
$3.09B
| $24.5M | 0.88% |
+400,000
| New | +$24.5M |
|
|
CLVS
28
DELISTED
Clovis Oncology, Inc.
CLVS
| $23.1M | 0.83% |
246,300
-53,700
| -18% | -$5.03M |
|
29
UnitedHealth
UNH
$279B
| $19.1M | 0.69% |
103,100
-71,900
| -41% | -$13.3M |
|
30
Medtronic
MDT
$118B
| $14.9M | 0.54% |
167,430
-45,600
| -21% | -$4.05M |
|
31
Puma Biotechnology
PBYI
$258M
| $13.1M | 0.47% |
+150,000
| New | +$13.1M |
|
32
Boston Scientific
BSX
$159B
| $12.6M | 0.45% |
+453,950
| New | +$12.6M |
|
|
HRC
33
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $9.95M | 0.36% |
+125,000
| New | +$9.95M |
|
34
Zoetis
ZTS
$67.6B
| $5.76M | 0.21% |
92,334
-607,666
| -87% | -$37.9M |
|
35
Baxter International
BAX
$12.1B
| $3.97M | 0.14% |
65,610
-609,390
| -90% | -$36.9M |
|
|
36
Align Technology
ALGN
$9.59B
| – | – |
-525,000
| Closed | -$60.2M |
|
37
Becton Dickinson
BDX
$54.3B
| – | – |
-25,174
| Closed | -$4.51M |
|
38
Cigna
CI
$80.2B
| – | – |
-100,720
| Closed | -$14.8M |
|
39
Quest Diagnostics
DGX
$20.1B
| – | – |
-78,982
| Closed | -$7.76M |
|
40
DexCom
DXCM
$30.9B
| – | – |
-900,000
| Closed | -$19.1M |
|
41
HCA Healthcare
HCA
$95.4B
| – | – |
-325,000
| Closed | -$28.9M |
|
42
Medpace
MEDP
$13.5B
| – | – |
-700,000
| Closed | -$20.9M |
|
|
43
Merck
MRK
$210B
| – | – |
-1,545,800
| Closed | -$93.7M |
|
44
Qiagen
QGEN
$10.1B
| – | – |
-1,650,347
| Closed | -$50.7M |
|
|
SYNH
45
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| – | – |
-1,700,000
| Closed | -$77.9M |
|
|
ALXN
46
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| – | – |
-950,000
| Closed | -$115M |
|
|
VAR
47
DELISTED
Varian Medical Systems, Inc.
VAR
| – | – |
0
| – | – |
|
|
AKRX
48
DELISTED
Akorn, Inc.
AKRX
| – | – |
-650,000
| Closed | -$15.7M |
|
|
ESRX
49
DELISTED
Express Scripts Holding Company
ESRX
| – | – |
0
| – | – |
|
|
MON
50
DELISTED
Monsanto Co
MON
| – | – |
-300,000
| Closed | -$34M |
|